Widely used:Recently Viewed
Clear All
$0 Mln
--
0.09
--
0
-378.21 %
--
--
--
-69610733
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Aditxt Inc (ADTX)
| -99.27 | -92.45 | -96.69 | -99.59 | -97.54 | -- | -- |
|
BSE Sensex*
| 13.08 | -1.05 | 2.13 | 24.69 | 11.60 | 16.47 | 11.89 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
|
|---|---|---|---|
|
Aditxt Inc (ADTX)
| -85.64 | -95.69 | -74.23 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Our rating system has guided millions of investors in the past 20 years.
$0.01 Mln
$0.33 Mln
$0.00 Mln
$0.09 Mln
$8.04 Mln
High
$1.80 - 564.00
5,388,680
NASDAQ: ADTX
Richmond, VA
https://www.aditxt.com
Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to... understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia. Address: 737 North Fifth Street, Richmond, VA, United States, 23219 Read more
The total asset value of Aditxt Inc (ADTX) stood at $ 49 Mln as on 30-Jun-24
The share price of Aditxt Inc (ADTX) is $1.94 (NASDAQ) as of 03-Oct-2024 16:29 EDT. Aditxt Inc (ADTX) has given a return of -97.54% in the last 3 years.
Aditxt Inc (ADTX) has a market capitalisation of $ 0 Mln as on 02-Oct-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Aditxt Inc (ADTX) is 0.09 times as on 02-Oct-2024, a 97% discount to its peers’ median range of 3.12 times.
Since, TTM earnings of Aditxt Inc (ADTX) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Aditxt Inc (ADTX) and enter the required number of quantities and click on buy to purchase the shares of Aditxt Inc (ADTX).
Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia. Address: 737 North Fifth Street, Richmond, VA, United States, 23219
The CEO & director of Mr. Amro A. Albanna. is Aditxt Inc (ADTX), and CFO & Sr. VP is Mr. Amro A. Albanna.
There is no promoter pledging in Aditxt Inc (ADTX).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
996
|
|
|
994
|
|
|
980
|
|
|
819
|
| Aditxt Inc. (ADTX) | Ratios |
|---|---|
|
Return on equity(%)
|
-378.21
|
|
Operating margin(%)
|
-7765.68
|
|
Net Margin(%)
|
-13038.63
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Aditxt Inc (ADTX) was $0 Mln.
$-0.76
